91 related articles for article (PubMed ID: 1093299)
1. Immunotherapy with cultured human cells and BCG.
Sokal JE; Aungst CW
Transplant Proc; 1975 Jun; 7(2):317-21. PubMed ID: 1093299
[No Abstract] [Full Text] [Related]
2. Immunotherapy of chronic myelocytic leukemia.
Sokal JE; Aungst CW; Grace JT
Natl Cancer Inst Monogr; 1973 Dec; 39():195-8. PubMed ID: 4595316
[No Abstract] [Full Text] [Related]
3. Use of Bacillus Calmette-Guérin as adjuvant in human cell vaccines.
Sokal JE; Aungst CW; Han T
Cancer Res; 1972 Jul; 32(7):1584-9. PubMed ID: 4624098
[No Abstract] [Full Text] [Related]
4. Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapy.
Sokal JE
J Surg Oncol; 1973 Jun; 5(6):557-66. PubMed ID: 4589652
[No Abstract] [Full Text] [Related]
5. The occurrence of antibodies against single-stranded DNA in the sera of patients with acute and chronic leukaemia.
Izui S; Lambert PH; Carpentier N; Miescher PA
Clin Exp Immunol; 1976 Jun; 24(3):379-84. PubMed ID: 780020
[TBL] [Abstract][Full Text] [Related]
6. Assessing patients' sarcoma-specific immune responses during immunotherapy.
Williams DE; Romero JJ; Sinkovics JG; Campos LT
Tex Med; 1975 Jun; 71(6):55-60. PubMed ID: 1056644
[No Abstract] [Full Text] [Related]
7. Immunotherapy with BCG and leukemic blast cells during complete remission of acute myeloid leukemia.
Gobbi M; Ruggero D; Baccarani M; Zaccaria A; Tomasini I; Tura S
Haematologica; 1977 Oct; 62(5):529-36. PubMed ID: 412739
[No Abstract] [Full Text] [Related]
8. Progress report on immunotherapy of chronic myeloid leukemia.
Sokal JE; Carpenter N; Nizet C
Boll Ist Sieroter Milan; 1978 Jul; 57(3):294-305. PubMed ID: 282900
[TBL] [Abstract][Full Text] [Related]
9. Active specific immunotherapy for acute myelogenous leukaemia.
Powles R
Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353
[No Abstract] [Full Text] [Related]
10. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
Simmons RL; Rios A
Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
[No Abstract] [Full Text] [Related]
11. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
[No Abstract] [Full Text] [Related]
12. BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer.
Schreinemachers L; Van der Meyden A; Steerenberg P; Feitz W; Groothuis D; De Jong W; Debruyne F
Chemioterapia; 1987 Jun; 6(2 Suppl):713-6. PubMed ID: 3334665
[No Abstract] [Full Text] [Related]
13. Immunotherapy of acute myelogenous leukemia in man.
Powles R
Natl Cancer Inst Monogr; 1973 Dec; 39():243-7. PubMed ID: 4595324
[No Abstract] [Full Text] [Related]
14. The effect of BCG on in vitro immune reactivity and clinical course in dogs treated surgically for osteosarcoma.
Bech-Nielsen S; Brodey RS; Fidler IJ; Abt DA; Reif JS
Eur J Cancer (1965); 1977 Jan; 13(1):33-41. PubMed ID: 321227
[No Abstract] [Full Text] [Related]
15. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
Mathé G; Halle-Pannenko O; Bourut C
Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
[No Abstract] [Full Text] [Related]
16. Editorial: BCG in cancer.
Br Med J; 1976 Jun; 1(6024):1487. PubMed ID: 776334
[No Abstract] [Full Text] [Related]
17. Hyperthermia increases the susceptibility of chondro- and osteosarcoma cells to natural killer cell-mediated lysis.
Kubista B; Trieb K; Blahovec H; Kotz R; Micksche M
Anticancer Res; 2002; 22(2A):789-92. PubMed ID: 12014651
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy by BCG against prostate adenocarcinomas in anatomical compartments.
Pollard M; Luckert PH
Anticancer Res; 1994; 14(6B):2691-4. PubMed ID: 7872703
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of growth and dissemination of Shay myelogenous leukemic tumor in rats by glucan and glucan activated macrophages.
Di Luzio NR; Mcnamee R; Jones E; Lassoff S; Sear W; Hoffmann EO
Adv Exp Med Biol; 1976; 73 Pt B():397-413. PubMed ID: 793341
[No Abstract] [Full Text] [Related]
20. BCG in the therapy of cancer.
Delmonte L; Oettgen HF
Clin Bull; 1975; 5(2):69-71. PubMed ID: 776445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
